Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9096600 N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitors

Patent 9096600 was granted and assigned to Incyte on August, 2015 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

All edits

Edits on 3 Jul, 2024

"update inverses"

edited on 3 Jul, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 12024522 Salts and processes of preparing a PI3K inhibitor

0

Edits on 6 Jun, 2024

"update inverses"

edited on 6 Jun, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11999751 Bicyclic heteroarylaminoalkyl phenyl derivatives as PI3K inhibitors

0

Edits on 10 Apr, 2024

"update inverses"

edited on 10 Apr, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11952367 Pyridine and pyridimine compounds as PI3K-gamma inhibitors

0

Edits on 14 Mar, 2024

"update inverses"

edited on 14 Mar, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11926630 Tertiary alcohols as PI3K-γ inhibitors

0

Edits on 3 Dec, 2023

"Add patent abstract"

edited on 3 Dec, 2023

Edits made to:

Article (+349 characters)

Article

Patent abstract

The present invention provides N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines derivatives that modulate the activity of phosphoinositide 3-kinases (PI3Ks) and are useful in the treatment of diseases related to the activity of PI3Ks including, for example, inflammatory disorders, immune-based disorders, cancer, and other diseases.

Edits on 29 Nov, 2023

"update inverses"

edited on 29 Nov, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11819505 Heterocyclylamines as PI3K inhibitors

0

Edits on 5 Oct, 2023

"update inverses"

edited on 5 Oct, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11773102 Heterocyclic compounds as PI3K-γ inhibitors

Edits on 22 May, 2023

"Remove leading 0 from patent number"

edited on 22 May, 2023

Edits made to:

Infobox (+1/-1 properties)

‌

US Patent 09096600 N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitors US Patent 9096600 N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitors

Infobox

Patent Number

090966000

Patent Number

90966000

Edits on 20 May, 2023

"Remove website redirecting to Patent Public Search front page"

edited on 20 May, 2023

Edits made to:

Infobox (-1 properties)

Infobox

Official Website

https://pdfpiw.uspto.gov/.piw?Docid=090966000

Edits on 24 Apr, 2023

"Entity importer update"

edited on 24 Apr, 2023

Infobox

Is a

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

090966000

Date of Patent

August 4, 2015

0

Patent Application Number

133295320

Date Filed

December 19, 2011

0

Official Website

https://pdfpiw.uspto.gov/.piw?Docid=090966000

Patent Primary Examiner

0

Edits on 8 Jun, 2022

"Entity importer update"

edited on 8 Jun, 2022

Edits made to:

Infobox (+1 properties)

Infobox

Website URL

https://pdfpiw.uspto.gov/.piw?Docid=09096600

Edits on 2 Jan, 2022

"Created via: Entity Importer"

created this topic on 2 Jan, 2022

Edits made to:

Infobox (+8 properties)

‌

US Patent 09096600 N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitors

Infobox

Is a

Current assignee

Patent jurisdiction

United States Patent and Trademark Office

Patent number

09096600

Date of patent

August 4, 2015

Patent application number

13329532

Date Filed

December 19, 2011

Patent primary examiner

Find more entities like US Patent 9096600 N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.